Adams H.P. Jr, Bendixen B.H., Kappelle L.J., Biller J., Love B.B., Gordon D.L., Marsh E.E. 3rd. Classification of Subtype of Acute Ischemic Stroke. Definitions for Use in a Multicenter Clinical Trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24(1):35–41. doi: 10.1161/01.str.24.1.35..
DOI: 10.1161/01.str.24.1.35
Nouh A., Hussain M., Mehta T., Yaghi S. Embolic Strokes of Unknown Source and Cryptogenic Stroke: Implications in Clinical Practice. Front Neurol. 2016;7:37. doi: 10.3389/fneur.2016.00037..
DOI: 10.3389/fneur.2016.00037
Kulesh A.A., Drobakha V.E., Shestakov V.V. Cryptogenic Stroke. Nevrologiya, neyropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2019;11(4):14–21. doi: 10.14412/2074-2711-2019-4-14-21..
DOI: 10.14412/2074-2711-2019-4-14-21
Ntaios G. Embolic Stroke of Undetermined Source: JACC Review Topic of the Week. J Am Coll Cardiol. 2020;75(3):333–340. doi: 10.1016/j.jacc.2019.11.024..
DOI: 10.1016/j.jacc.2019.11.024
Pristipino C., Sievert H., D’Ascenzo F., Louis Mas J., Meier B., Scacciatella P. et al. European Position Paper on the Management of Patients with Patent Foramen Ovale. General Approach and Left Circulation Thromboembolism. Eur Heart J. 2019;40(38):3182–3195. doi: 10.1093/eurheartj/ehy649..
DOI: 10.1093/eurheartj/ehy649
Giugliano R.P., Pedersen T.R., Saver J.L., Sever P.S., Keech A.C., Bohula E.A. et al. Stroke Prevention With the PCSK9 (Proprotein Convertase Subtilisin-Kexin Type 9) Inhibitor Evolocumab Added to Statin in High-Risk Patients With Stable Atherosclerosis. Stroke. 2020;51(5):1546–1554. doi: 10.1161/STROKEAHA.119.027759..
DOI: 10.1161/STROKEAHA.119.027759
Johnston S.C., Amarenco P., Denison H., Evans S.R., Himmelmann A., James S. et al. Ticagrelor and Aspirin or Aspirin Alone in Acute Ischemic Stroke or TIA. N Engl J Med. 2020;383(3):207–217. doi: 10.1056/NEJMoa1916870..
DOI: 10.1056/NEJMoa1916870
Sharma M., Hart R.G., Connolly S.J., Bosch J., Shestakovska O., Ng K.K.H. et al. Stroke Outcomes in the COMPASS Trial. Circulation. 2019;139(9):1134–1145. doi: 10.1161/CIRCULATIONAHA.118.035864..
DOI: 10.1161/CIRCULATIONAHA.118.035864
Hart R.G., Diener H.C., Coutts S.B., Easton J.D., Granger C.B., O’Donnell M.J. et al. Embolic Strokes of Undetermined Source: The Case for a New Clinical Construct. Lancet Neurol. 2014;13(4):429–438. doi: 10.1016/S1474-4422(13)70310-7..
DOI: 10.1016/S1474-4422(13)70310-7
Masina M., Cicognani A., Lofiego C., Malservisi S., Parlangeli R., Lombardi A. Embolic Stroke of Undetermined Source: A Retrospective Analysis from an Italian Stroke Unit. Italian J Med. 2016;10(3):202–206. doi: 10.4081/itjm.2016.690..
DOI: 10.4081/itjm.2016.690
Ntaios G., Papavasileiou V., Milionis H., Makaritsis K., Manios E., Spengos K. et al. Embolic Strokes of Undetermined Source in the Athens Stroke Registry: A Descriptive Analysis. Stroke. 2015;46(1):176–181. doi: 10.1161/STROKEAHA.114.007240..
DOI: 10.1161/STROKEAHA.114.007240
Perera K.S., Vanassche T., Bosch J., Giruparajah M., Swaminathan B., Mattina K.R. et al. Embolic Strokes of Undetermined Source: Prevalence and Patient Features in the ESUS Global Registry. Int J Stroke. 2016;11(5):526–533. doi: 10.1177/1747493016641967..
DOI: 10.1177/1747493016641967
Li L., Yiin G.S., Geraghty O.C., Schulz U.G., Kuker W., Mehta Z., Rothwell P.M. Incidence, Outcome, Risk Factors, and Long-Term Prognosis of Cryptogenic Transient Ischaemic Attack and Ischaemic Stroke: A Population-Based Study. Lancet Neurol. 2015;14(9):903–913. doi: 10.1016/S1474-4422(15)00132-5..
DOI: 10.1016/S1474-4422(15)00132-5
Putaala J., Nieminen T., Haapaniemi E., Meretoja A., Rantanen K., Heikkinen N. et al. Undetermined Stroke with an Embolic Pattern – a Common Phenotype with High Early Recurrence Risk. Ann Med. 2015;47(5):406–413. doi: 10.3109/07853890.2015.1057612..
DOI: 10.3109/07853890.2015.1057612
Ntaios G., Papavasileiou V., Milionis H., Makaritsis K., Vemmou A., Koroboki E. et al. Embolic Strokes of Undetermined Source in the Athens Stroke Registry: An Outcome Analysis. Stroke. 2015;46(8):2087–2093. doi: 10.1161/STROKEAHA.115.009334..
DOI: 10.1161/STROKEAHA.115.009334
Hart R.G., Catanese L., Perera K.S., Ntaios G., Connolly S.J. Embolic Stroke of Undetermined Source: A Systematic Review and Clinical Update. Stroke. 2017;48(4):867–872. doi: 10.1161/STROKEAHA.116.016414..
DOI: 10.1161/STROKEAHA.116.016414
Ntaios G., Wintermark M., Michel P. Supracardiac Atherosclerosis in Embolic Stroke of Undetermined Source: The Underestimated Source. Eur Heart J. 2020;ehaa218. doi: 10.1093/eurheartj/ehaa218..
DOI: 10.1093/eurheartj/ehaa218
Cui X., Li Y., Liu J., He S., Liu M. Aortic Arch Atheroma and the Risk of Stroke: A Meta-Analysis. J Evid Based Med. 2014;7(3):185–191. doi: 10.1111/jebm.12113..
DOI: 10.1111/jebm.12113
Censori B., Colombo F., Valsecchi M.G., Clivati L., Zonca A., Camerlingo M. et al. Early Transoesophageal Echocardiography in Cryptogenic and Lacunar Stroke and Transient Ischaemic Attack. J Neurol Neurosurg Psychiatry. 1998;64(5):624– 627. doi: 10.1136/jnnp.64.5.624..
DOI: 10.1136/jnnp.64.5.624
Gu X., He Y., Li Z., Kontos M.C., Paulsen W.H., Arrowood J.A., Nixon J.V. Comparison of Frequencies of Patent Foramen Ovale and Thoracic Aortic Atherosclerosis in Patients with Cryptogenic Ischemic Stroke Undergoing Transesophageal Echocardiography. Am J Cardiol. 2011;108(12):1815–1819. doi: 10.1016/j.amjcard.2011.07.058..
DOI: 10.1016/j.amjcard.2011.07.058
Harloff A., Simon J., Brendecke S., Assefa D., Helbing T., Frydrychowicz A. et al. Complex Plaques in the Proximal Descending Aorta: An Underestimated Embolic Source of Stroke. Stroke. 2010;41(6):1145–1150. doi: 10.1161/STROKEAHA.109.577775..
DOI: 10.1161/STROKEAHA.109.577775
Wehrum T., Dragonu I., Strecker C., Schuchardt F., Hennemuth A., Drexl J. et al. Aortic Atheroma as a Source of Stroke – Assessment of Embolization Risk Using 3D CMR in Stroke Patients and Controls. J Cardiovasc Magn Reson. 2017;19(1):67. doi: 10.1186/s12968-017-0379-x..
DOI: 10.1186/s12968-017-0379-x
Ay H., Benner T., Arsava E.M., Furie K.L., Singhal A.B., Jensen M.B. et al. A Computerized Algorithm for Etiologic Classification of Ischemic Stroke: The Causative Classification of Stroke System. Stroke. 2007;38(11):2979–2984. doi: 10.1161/STROKEAHA.107.490896..
DOI: 10.1161/STROKEAHA.107.490896
Amarenco P., Cohen A., Tzourio C., Bertrand B., Hommel M., Besson G. et al. Atherosclerotic Disease of the Aortic Arch and the Risk of Ischemic stroke. N Engl J Med. 1994;331(22):1474–1479. doi: 10.1056/NEJM199412013312202..
DOI: 10.1056/NEJM199412013312202
Kronzon I., Tunick P.A. Aortic Atherosclerotic Disease and Stroke. Circulation. 2006;114(1):63–75. doi: 10.1161/CIRCULATIONAHA.105.593418..
DOI: 10.1161/CIRCULATIONAHA.105.593418
Ntaios G., Pearce L.A., Meseguer E., Endres M., Amarenco P., Ozturk S. et al. Aortic Arch Atherosclerosis in Patients With Embolic Stroke of Undetermined Source: An Exploratory Analysis of the NAVIGATE ESUS Trial. Stroke. 2019;50(11):3184– 3190. doi: 10.1161/STROKEAHA.119.025813..
DOI: 10.1161/STROKEAHA.119.025813
Di Tullio M.R., Russo C., Jin Z., Sacco R.L., Mohr J.P., Homma S. Aortic Arch Plaques and Risk of Recurrent Stroke and Death. Circulation. 2009;119(17):2376–2382. doi: 10.1161/CIRCULATIONAHA.108.811935..
DOI: 10.1161/CIRCULATIONAHA.108.811935
Amarenco P., Davis S., Jones E.F., Cohen A.A., Heiss W.D., Kaste M. et al. Clopidogrel Plus Aspirin versus Warfarin in Patients with Stroke and Aortic Arch Plaques. Stroke. 2014;45(5):1248–1257. doi: 10.1161/STROKEAHA.113.004251..
DOI: 10.1161/STROKEAHA.113.004251
Kernan W.N., Ovbiagele B., Black H.R., Bravata D.M., Chimowitz M.I., Ezekowitz M.D. et al. Guidelines for the Prevention of Stroke in Patients with Stroke and Transient Ischemic Attack: A Guideline for Healthcare Professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45(7):2160–2236. doi: 10.1161/STR.0000000000000024..
DOI: 10.1161/STR.0000000000000024
Kamtchum-Tatuene J., Wilman A., Saqqur M., Shuaib A., Jickling G.C. Carotid Plaque With High-Risk Features in Embolic Stroke of Undetermined Source: Systematic Review and Meta-Analysis. Stroke. 2020;51(1):311–314. doi: 10.1161/STROKEAHA.119.027272..
DOI: 10.1161/STROKEAHA.119.027272
Ospel J.M., Singh N., Marko M., Almekhlafi M., Dowlatshahi D., Puig J. et al. Prevalence of Ipsilateral Nonstenotic Carotid Plaques on Computed Tomography Angiography in Embolic Stroke of Undetermined Source. Stroke. 2020;51(6):1743–1749. doi: 10.1161/STROKEAHA.120.029404..
DOI: 10.1161/STROKEAHA.120.029404
Kopczak A., Schindler A., Bayer-Karpinska A., Koch M.L., Sepp D., Zeller J. et al. Complicated Carotid Artery Plaques as a Cause of Cryptogenic Stroke. J Am Coll Cardiol. 2020;76(19):2212–2222. doi: 10.1016/j.jacc.2020.09.532..
DOI: 10.1016/j.jacc.2020.09.532
Fitzgerald S., Dai D., Wang S., Douglas A., Kadirvel R., Layton K.F. et al. PlateletRich Emboli in Cerebral Large Vessel Occlusion Are Associated With a Large Artery Atherosclerosis Source. Stroke. 2019;50(7):1907–1910. doi: 10.1161/STROKEAHA.118.024543..
DOI: 10.1161/STROKEAHA.118.024543
Boeckh-Behrens T., Kleine J.F., Zimmer C., Neff F., Scheipl F., Pelisek J. et al. Thrombus Histology Suggests Cardioembolic Cause in Cryptogenic Stroke. Stroke. 2016;47(7):1864–1871. doi: 10.1161/STROKEAHA.116.013105..
DOI: 10.1161/STROKEAHA.116.013105
Goyal M., Singh N., Marko M., Hill M.D., Menon B.K., Demchuk A. et al. Embolic Stroke of Undetermined Source and Symptomatic Nonstenotic Carotid Disease. Stroke. 2020;51(4):1321–1325. doi: 10.1161/STROKEAHA.119.028853..
DOI: 10.1161/STROKEAHA.119.028853
Paraskevas K.I., Veith F.J., Spence J.D. How to Identify Which Patients with Asymptomatic Carotid Stenosis Could Benefit from Endarterectomy or Stenting. Stroke Vasc Neurol. 2018;3(2):92–100. doi: 10.1136/svn-2017-000129..
DOI: 10.1136/svn-2017-000129
Singh N., Marko M., Ospel J.M., Goyal M., Almekhlafi M. The Risk of Stroke and TIA in Nonstenotic Carotid Plaques: A Systematic Review and Meta-Analysis. AJNR Am J Neuroradiol. 2020;41(8):1453–1459. doi: 10.3174/ajnr.A6613..
DOI: 10.3174/ajnr.A6613
Amarenco P., Bogousslavsky J., Caplan L.R., Donnan G.A., Wolf M.E., Hennerici M.G. The ASCOD Phenotyping of Ischemic Stroke (Updated ASCO Phenotyping). Cerebrovasc Dis. 2013;36(1):1–5. doi: 10.1159/000352050..
DOI: 10.1159/000352050
Ntaios G., Swaminathan B., Berkowitz S.D., Gagliardi R.J., Lang W., Siegler J.E. et al. Efficacy and Safety of Rivaroxaban Versus Aspirin in Embolic Stroke of Undetermined Source and Carotid Atherosclerosis. Stroke. 2019;50(9):2477– 2485. doi: 10.1161/STROKEAHA.119.025168..
DOI: 10.1161/STROKEAHA.119.025168
Rothwell P.M., Eliasziw M., Gutnikov S.A., Fox A.J., Taylor D.W., Mayberg M.R. et al. Analysis of Pooled Data from the Randomised Controlled Trials of Endarterectomy for Symptomatic Carotid Stenosis. Lancet. 2003;361(9352):107–116. doi: 10.1016/s0140-6736(03)12228-3..
DOI: 10.1016/s0140-6736(03)12228-3
Naylor A.R., Ricco J.B., de Borst G.J., Debus S., de Haro J., Halliday A. et al. Editor’s Choice – Management of Atherosclerotic Carotid and Vertebral Artery Disease: 2017 Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg. 2018;55(1):3–81. doi: 10.1016/j.ejvs.2017.06.021..
DOI: 10.1016/j.ejvs.2017.06.021
Altaf N., Daniels L., Morgan P.S., Auer D., MacSweeney S.T., Moody A.R., Gladman J.R. Detection of Intraplaque Hemorrhage by Magnetic Resonance Imaging in Symptomatic Patients with Mild to Moderate Carotid Stenosis Predicts Recurrent Neurological Events. J Vasc Surg. 2008;47(2):337–342. doi: 10.1016/j.jvs.2007.09.064..
DOI: 10.1016/j.jvs.2007.09.064
Kashiwazaki D., Shiraishi K., Yamamoto S., Kamo T., Uchino H., Saito H. et al. Efficacy of Carotid Endarterectomy for Mild (<50[%]) Symptomatic Carotid Stenosis with Unstable Plaque. World Neurosurg. 2019;121:e60–e69. doi: 10.1016/j.wneu.2018.09.013..
DOI: 10.1016/j.wneu.2018.09.013
Coutinho J.M., Derkatch S., Potvin A.R., Tomlinson G., Casaubon L.K., Silver F.L., Mandell D.M. Carotid Artery Web and Ischemic Stroke: A Case-Control Study. Neurology. 2017;88(1):65–69. doi: 10.1212/WNL.0000000000003464..
DOI: 10.1212/WNL.0000000000003464
Choi P.M., Singh D., Trivedi A., Qazi E., George D., Wong J. et al. Carotid Webs and Recurrent Ischemic Strokes in the Era of CT Angiography. AJNR Am J Neuroradiol. 2015;36(11):2134–2139. doi: 10.3174/ajnr.A4431..
DOI: 10.3174/ajnr.A4431
Wojcik K., Milburn J., Vidal G., Tarsia J., Steven A. Survey of Current Management Practices for Carotid Webs. Ochsner J. 2019;19(4):296–302. doi: 10.31486/toj.18.0114..
DOI: 10.31486/toj.18.0114
Compagne K.C.J., van Es A.C.G.M., Berkhemer O.A., Borst J., Roos Y.B.W.E.M., van Oostenbrugge R.J. et al. Prevalence of Carotid Web in Patients with Acute Intracranial Stroke Due to Intracranial Large Vessel Occlusion. Radiology. 2018;286(3):1000–1007. doi: 10.1148/radiol.2017170094..
DOI: 10.1148/radiol.2017170094
Hu H., Zhang X., Zhao J., Li Y., Zhao Y. Transient Ischemic Attack and Carotid Web. AJNR Am J Neuroradiol. 2019;40(2):313–318. doi: 10.3174/ajnr.A5946..
DOI: 10.3174/ajnr.A5946
Joux J., Boulanger M., Jeannin S., Chausson N., Hennequin J.L., Molinié V. et al. Association between Carotid Bulb Diaphragm and Ischemic Stroke in Young Afro-Caribbean Patients: A Population-Based Case-Control Study. Stroke. 2016;47(10):2641–2644. doi: 10.1161/STROKEAHA.116.013918..
DOI: 10.1161/STROKEAHA.116.013918
Sajedi P.I., Gonzalez J.N., Cronin C.A., Kouo T., Steven A., Zhuo J. et al. Carotid Bulb Webs as a Cause of “Cryptogenic” Ischemic Stroke. AJNR Am J Neuroradiol. 2017;38(7):1399–1404. doi: 10.3174/ajnr.A5208..
DOI: 10.3174/ajnr.A5208
Kim S.J., Allen J.W., Bouslama M., Nahab F., Frankel M.R., Nogueira R.G., Haussen D.C. Carotid Webs in Cryptogenic Ischemic Strokes: A Matched Case-Control Study. J Stroke Cerebrovasc Dis. 2019;28(12):104402. doi: 10.1016/j.jstrokecerebrovasdis.2019.104402..
DOI: 10.1016/j.jstrokecerebrovasdis.2019.104402
Madaelil T.P., Grossberg J.A., Nogueira R.G., Anderson A., Barreira C., Frankel M., Haussen D.C. Multimodality Imaging in Carotid Web. Front Neurol. 2019;10:220. doi: 10.3389/fneur.2019.00220..
DOI: 10.3389/fneur.2019.00220
Luo X., Li Z. Ultrasonic Risk Stratification of Carotid Web. Echocardiography. 2019;36(11):2103–2107. doi: 10.1111/echo.14521..
DOI: 10.1111/echo.14521
Haussen D.C., Grossberg J.A., Bouslama M., Pradilla G., Belagaje S., Bianchi N. et al. Carotid Web (Intimal Fibromuscular Dysplasia) Has High Stroke Recurrence Risk and Is Amenable to Stenting. Stroke. 2017;48(11):3134–3137. doi: 10.1161/STROKEAHA.117.019020..
DOI: 10.1161/STROKEAHA.117.019020
Phair J., Trestman E.B., Yean C., Lipsitz E.C. Endarterectomy for a Symptomatic Carotid Web. Vascular. 2017;25(5):553–556. doi: 10.1177/1708538116684940..
DOI: 10.1177/1708538116684940
Qureshi A.I., Caplan L.R. Intracranial Atherosclerosis. Lancet. 2014;383(9921):984–998. doi: 10.1016/S0140-6736(13)61088-0..
DOI: 10.1016/S0140-6736(13)61088-0
Hurford R., Wolters F.J., Li L., Lau K.K., Küker W., Rothwell P.M. Prevalence, Predictors, and Prognosis of Symptomatic Intracranial Stenosis in Patients with Transient Ischaemic Attack or Minor Stroke: A Population-Based Cohort Study. Lancet Neurol. 2020;19(5):413–421. doi: 10.1016/S1474-4422(20)30079-X..
DOI: 10.1016/S1474-4422(20)30079-X
Hoshino T., Sissani L., Labreuche J., Ducrocq G., Lavallée P.C., Meseguer E. et al. Prevalence of Systemic Atherosclerosis Burdens and Overlapping Stroke Etiologies and Their Associations With Long-Term Vascular Prognosis in Stroke With Intracranial Atherosclerotic Disease. JAMA Neurol. 2018;75(2):203–211. doi: 10.1001/jamaneurol.2017.3960..
DOI: 10.1001/jamaneurol.2017.3960
Mazighi M., Labreuche J., Gongora-Rivera F., Duyckaerts C., Hauw J.J., Amarenco P. Autopsy Prevalence of Intracranial Atherosclerosis in Patients with Fatal Stroke. Stroke. 2008;39(4):1142–1147. doi: 10.1161/STROKEAHA.107.496513..
DOI: 10.1161/STROKEAHA.107.496513
Krasteva M.P., Lau K.K., Mordasini P., Tsang A.C.O., Heldner M.R. Intracranial Atherosclerotic Stenoses: Pathophysiology, Epidemiology, Risk Factors and Current Therapy Options. Adv Ther. 2020;37(5):1829–1865. doi: 10.1007/s12325-020-01291-4..
DOI: 10.1007/s12325-020-01291-4
Al Kasab S., Derdeyn C.P., Guerrero W.R., Limaye K., Shaban A., Adams H.P. Jr. Intracranial Large and Medium Artery Atherosclerotic Disease and Stroke. J Stroke Cerebrovasc Dis. 2018;27(7):1723–1732. doi: 10.1016/j.jstrokecerebrovasdis.2018.02.050..
DOI: 10.1016/j.jstrokecerebrovasdis.2018.02.050
Petrone L., Nannoni S., Del Bene A., Palumbo V., Inzitari D. Branch Atheromatous Disease: A Clinically Meaningful, Yet Unproven Concept. Cerebrovasc Dis. 2016;41(1–2):87–95. doi: 10.1159/000442577..
DOI: 10.1159/000442577
Feng X., Chan K.L., Lan L., Abrigo J., Liu J., Fang H. et al. Stroke Mechanisms in Symptomatic Intracranial Atherosclerotic Disease: Classification and Clinical Implications. Stroke. 2019;50(10):2692–2699. doi: 10.1161/STROKEAHA.119.025732..
DOI: 10.1161/STROKEAHA.119.025732
Planas-Ballvé A., Crespo A.M., Aguilar L.M., Hernández-Pérez M., Canento T., Dorado L. et al. The Barcelona-Asymptomatic Intracranial Atherosclerosis study: Subclinical Intracranial Atherosclerosis as Predictor of Long-Term Vascular Events. Atherosclerosis. 2019;282:132–136. doi: 10.1016/j.atherosclerosis.2019.01.022..
DOI: 10.1016/j.atherosclerosis.2019.01.022
Kamel H., Gialdini G., Baradaran H., Giambrone A.E., Navi B.B., Lerario M.P. et al. Cryptogenic Stroke and Nonstenosing Intracranial Calcified Atherosclerosis. J Stroke Cerebrovasc Dis. 2017;26(4):863–870. doi: 10.1016/j.jstrokecerebrovasdis.2016.10.035..
DOI: 10.1016/j.jstrokecerebrovasdis.2016.10.035
Amarenco P. Underlying Pathology of Stroke of Unknown Cause (Cryptogenic Stroke). Cerebrovasc Dis. 2009;27(Suppl 1):97–103. doi: 10.1159/000200446..
DOI: 10.1159/000200446
Wang Y., Liu X., Wu X., Degnan A.J., Malhotra A., Zhu C. Culprit Intracranial Plaque without Substantial Stenosis in Acute Ischemic Stroke on Vessel Wall MRI: A Systematic Review. Atherosclerosis. 2019;287:112–121. doi: 10.1016/j.atherosclerosis.2019.06.907..
DOI: 10.1016/j.atherosclerosis.2019.06.907
Bodle J.D., Feldmann E., Swartz R.H., Rumboldt Z., Brown T., Turan T.N. HighResolution Magnetic Resonance Imaging: An Emerging Tool for Evaluating Intracranial Arterial Disease. Stroke. 2013;44(1):287–292. doi: 10.1161/STROKEAHA.112.664680..
DOI: 10.1161/STROKEAHA.112.664680
Zhang D.F., Chen Y.C., Chen H., Zhang W.D., Sun J., Mao C.N. et al. A HighResolution MRI Study of Relationship between Remodeling Patterns and Ischemic Stroke in Patients with Atherosclerotic Middle Cerebral Artery Stenosis. Front Aging Neurosci. 2017;9:140. doi: 10.3389/fnagi.2017.00140..
DOI: 10.3389/fnagi.2017.00140
Leao D.J., Agarwal A., Mohan S., Bathla G. Intracranial Vessel Wall Imaging: Applications, Interpretation, and Pitfalls. Clin Radiol. 2020;75(10):730–739. doi: 10.1016/j.crad.2020.02.006..
DOI: 10.1016/j.crad.2020.02.006
Lee H.N., Ryu C.W., Yun S.J. Vessel-Wall Magnetic Resonance Imaging of Intracranial Atherosclerotic Plaque and Ischemic Stroke: A Systematic Review and Meta-Analysis. Front Neurol. 2018;9:1032. doi: 10.3389/fneur.2018.01032..
DOI: 10.3389/fneur.2018.01032
Schaafsma J.D., Rawal S., Coutinho J.M., Rasheedi J., Mikulis D.J., Jaigobin C. et al. Diagnostic Impact of Intracranial Vessel Wall MRI in 205 Patients with Ischemic Stroke or TIA. AJNR Am J Neuroradiol. 2019;40(10):1701–1706. doi: 10.3174/ajnr.A6202..
DOI: 10.3174/ajnr.A6202
Banerjee C., Chimowitz M.I. Stroke Caused by Atherosclerosis of the Major Intracranial Arteries. Circ Res. 2017;120(3):502–513. doi: 10.1161/CIRCRESAHA.116.308441..
DOI: 10.1161/CIRCRESAHA.116.308441
Chimowitz M.I., Lynn M.J., Howlett-Smith H., Stern B.J., Hertzberg V.S., Frankel M.R. et al. Comparison of Warfarin and Aspirin for Symptomatic Intracranial Arterial Stenosis. N Engl J Med. 2005;352(13):1305–1316. doi: 10.1056/NEJMoa043033..
DOI: 10.1056/NEJMoa043033
Derdeyn C.P., Chimowitz M.I., Lynn M.J., Fiorella D., Turan T.N., Janis L.S. et al. Aggressive Medical Treatment with or without Stenting in High-Risk Patients with Intracranial Artery Stenosis (SAMMPRIS): The Final Results of a Randomised Trial. Lancet. 2014;383(9914):333–341. doi: 10.1016/S0140-6736(13)62038-3..
DOI: 10.1016/S0140-6736(13)62038-3
Turan T.N., Nizam A., Lynn M.J., Egan B.M., Le N.A., Lopes-Virella M.F. et al. Relationship between Risk Factor Control and Vascular Events in the SAMMPRIS Trial. Neurology. 2017;88(4):379–385. doi: 10.1212/WNL.0000000000003534..
DOI: 10.1212/WNL.0000000000003534
Waters M.F., Hoh B.L., Lynn M.J., Kwon H.M., Turan T.N., Derdeyn C.P. et al. Factors Associated With Recurrent Ischemic Stroke in the Medical Group of the SAMMPRIS Trial. JAMA Neurol. 2016;73(3):308–315. doi: 10.1001/jamaneurol.2015.4315..
DOI: 10.1001/jamaneurol.2015.4315
Kamel H., Pearce L.A., Ntaios G., Gladstone D.J., Perera K., Roine R.O. et al. Atrial Cardiopathy and Nonstenosing Large Artery Plaque in Patients With Embolic Stroke of Undetermined Source. Stroke. 2020;51(3):938–943. doi: 10.1161/strokeaha.119.028154..
DOI: 10.1161/strokeaha.119.028154
Ntaios G., Perlepe K., Sirimarco G., Strambo D., Eskandari A., Karagkiozi E. et al. Carotid Plaques and Detection of Atrial Fibrillation in Embolic Stroke of Undetermined Source. Neurology. 2019;92(23):e2644–e2652. doi: 10.1212/WNL.0000000000007611..
DOI: 10.1212/WNL.0000000000007611
Imori Y., Akasaka T., Ochiai T., Oyama K., Tobita K., Shishido K. et al. Co-Existence of Carotid Artery Disease, Renal Artery Stenosis, and Lower Extremity Peripheral Arterial Disease in Patients with Coronary Artery Disease. Am J Cardiol. 2014;113(1):30–35. doi: 10.1016/j.amjcard.2013.09.015..
DOI: 10.1016/j.amjcard.2013.09.015